Skip to main content
. 2021 Jan 17;6(4):995–1002. doi: 10.1016/j.ekir.2021.01.007

Figure 2.

Figure 2

(a) Acute rejection comparison between low-dose rabbit antithymocyte globulin (rATG) and standard-dose rATG exposure groups at 12 months after kidney transplant. (b) The development of de novo donor-specific antibody comparison between low-dose rATG and standard-dose rATG exposure groups at 12 months after kidney transplant.